Header Logo

Mohit Chopra

Concepts (129)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
4
2025
81
0.690
 Why?
Depressive Disorder
3
2009
288
0.680
 Why?
Stress Disorders, Post-Traumatic
3
2016
407
0.680
 Why?
Opioid-Related Disorders
5
2025
525
0.560
 Why?
Memantine
3
2014
23
0.550
 Why?
Methadone
3
2025
140
0.550
 Why?
Health Status
2
2016
451
0.460
 Why?
Excitatory Amino Acid Antagonists
2
2013
38
0.460
 Why?
Social Stigma
1
2016
75
0.450
 Why?
Obsessive-Compulsive Disorder
1
2011
36
0.350
 Why?
Benzodiazepines
1
2011
106
0.340
 Why?
Patient Acceptance of Health Care
1
2016
495
0.340
 Why?
Narcotics
2
2025
57
0.340
 Why?
Disulfiram
2
2025
5
0.310
 Why?
Alzheimer Disease
3
2014
770
0.300
 Why?
Quality of Life
2
2016
1270
0.300
 Why?
Apolipoprotein E4
1
2009
46
0.300
 Why?
Antipsychotic Agents
1
2011
307
0.290
 Why?
Methadyl Acetate
1
2008
1
0.290
 Why?
Reward
1
2009
89
0.290
 Why?
Psychiatric Status Rating Scales
2
2013
393
0.290
 Why?
Narcotic Antagonists
2
2014
130
0.280
 Why?
Naloxone
1
2008
51
0.280
 Why?
Buprenorphine
2
2014
197
0.260
 Why?
Cognition Disorders
1
2008
223
0.260
 Why?
Aging
1
2013
766
0.260
 Why?
Alcohol Deterrents
1
2025
6
0.230
 Why?
Dementia
1
2008
273
0.220
 Why?
Geriatric Assessment
1
2006
161
0.220
 Why?
Long-Term Care
1
2006
179
0.220
 Why?
Aged
12
2016
14958
0.210
 Why?
Male
19
2025
31083
0.210
 Why?
Opiate Substitution Treatment
3
2025
222
0.200
 Why?
Hallucinations
1
2003
18
0.200
 Why?
Vitamin E
2
2014
55
0.200
 Why?
Depression
3
2016
916
0.190
 Why?
Female
18
2025
34131
0.190
 Why?
Treatment Refusal
1
2003
56
0.190
 Why?
Mental Competency
1
2003
62
0.190
 Why?
Anxiety
3
2016
438
0.190
 Why?
Comorbidity
3
2016
1126
0.190
 Why?
Informed Consent
1
2003
142
0.180
 Why?
Antioxidants
2
2014
266
0.170
 Why?
Attitude to Health
1
2003
296
0.170
 Why?
Nursing Homes
1
2006
675
0.160
 Why?
Humans
21
2025
65554
0.160
 Why?
Decision Making
1
2003
420
0.150
 Why?
Double-Blind Method
6
2025
749
0.140
 Why?
Severity of Illness Index
5
2014
1575
0.130
 Why?
Dose-Response Relationship, Drug
3
2025
880
0.130
 Why?
Veterans
3
2016
799
0.130
 Why?
Cyclohexanecarboxylic Acids
1
2014
9
0.110
 Why?
Dopamine Agents
1
2014
11
0.100
 Why?
Amines
1
2014
31
0.100
 Why?
Sertraline
1
2014
59
0.100
 Why?
gamma-Aminobutyric Acid
1
2014
77
0.100
 Why?
Aged, 80 and over
4
2014
5620
0.100
 Why?
Alcohol-Related Disorders
1
2013
37
0.090
 Why?
Alcoholism
1
2016
328
0.090
 Why?
Adult
8
2025
17417
0.090
 Why?
Longitudinal Studies
2
2013
1287
0.090
 Why?
Motivation
1
2014
295
0.090
 Why?
Disease Progression
2
2014
1218
0.090
 Why?
Combat Disorders
1
2011
11
0.090
 Why?
Patient Compliance
2
2014
365
0.090
 Why?
Activities of Daily Living
2
2014
292
0.080
 Why?
Life Change Events
1
2011
66
0.080
 Why?
Internet
1
2014
465
0.080
 Why?
Wounds and Injuries
1
2013
261
0.080
 Why?
Amphetamine-Related Disorders
1
2009
11
0.080
 Why?
Methamphetamine
1
2009
25
0.080
 Why?
Chronic Disease
1
2013
757
0.080
 Why?
Directive Counseling
1
2009
39
0.080
 Why?
Arkansas
1
2008
4
0.070
 Why?
Benzhydryl Compounds
1
2009
61
0.070
 Why?
Logistic Models
2
2011
1282
0.070
 Why?
Cocaine
2
2025
101
0.070
 Why?
Secondary Prevention
1
2009
164
0.070
 Why?
United States
3
2013
8131
0.070
 Why?
Self Concept
1
2008
117
0.070
 Why?
Paroxetine
2
2004
16
0.070
 Why?
Substance Withdrawal Syndrome
1
2008
124
0.060
 Why?
Middle Aged
6
2025
18277
0.060
 Why?
Sex Characteristics
1
2008
212
0.060
 Why?
Neuropsychological Tests
1
2008
410
0.060
 Why?
Psychometrics
1
2008
393
0.060
 Why?
Multivariate Analysis
1
2008
938
0.060
 Why?
Mental Health Services
2
2011
308
0.060
 Why?
Dysthymic Disorder
1
2005
8
0.060
 Why?
Psychotherapy
1
2006
102
0.060
 Why?
Mortality
1
2006
161
0.050
 Why?
Pindolol
1
2004
2
0.050
 Why?
Prolactin
1
2004
40
0.050
 Why?
Antidepressive Agents
1
2006
230
0.050
 Why?
Antidepressive Agents, Second-Generation
1
2004
30
0.050
 Why?
Tryptophan
1
2004
56
0.050
 Why?
Disability Evaluation
1
2005
218
0.050
 Why?
Treatment Outcome
3
2025
5822
0.050
 Why?
Combined Modality Therapy
2
2014
375
0.050
 Why?
Adrenergic beta-Antagonists
1
2004
152
0.050
 Why?
Hydrocortisone
1
2004
194
0.050
 Why?
Cross-Sectional Studies
2
2011
2700
0.050
 Why?
Drug Therapy, Combination
2
2014
473
0.050
 Why?
Surveys and Questionnaires
1
2008
2782
0.040
 Why?
Follow-Up Studies
1
2005
2510
0.040
 Why?
Primary Health Care
1
2005
722
0.040
 Why?
Adolescent
1
2009
6377
0.040
 Why?
Remission Induction
2
2011
150
0.030
 Why?
Diagnostic and Statistical Manual of Mental Disorders
2
2011
121
0.030
 Why?
Retrospective Studies
1
2008
6884
0.030
 Why?
GABA Agonists
1
2014
4
0.030
 Why?
Diagnosis, Dual (Psychiatry)
1
2014
89
0.030
 Why?
Cross-Over Studies
2
2004
164
0.030
 Why?
Cholinesterase Inhibitors
1
2014
50
0.030
 Why?
Residence Characteristics
1
2014
234
0.020
 Why?
Medication Adherence
1
2014
199
0.020
 Why?
Recurrence
1
2014
661
0.020
 Why?
Risk Factors
2
2011
5441
0.020
 Why?
Caregivers
1
2014
292
0.020
 Why?
Analgesics, Opioid
1
2014
537
0.020
 Why?
Self Report
1
2010
393
0.020
 Why?
Sex Factors
1
2011
997
0.020
 Why?
Alcohol Drinking
1
2010
322
0.020
 Why?
Pilot Projects
1
2009
1018
0.010
 Why?
Mass Screening
1
2011
706
0.010
 Why?
Fluoxetine
1
2004
45
0.010
 Why?
Young Adult
1
2014
4831
0.010
 Why?
Drug Administration Schedule
1
2004
301
0.010
 Why?
Substance-Related Disorders
1
2011
749
0.010
 Why?
Chopra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (129)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_